Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study by Lane, JCE, Weaver, J, Kostka, K, Burn, E, Kolovos, S, Prats-Uribe, A, Xie, J, Newby, D, Prieto-Alhambra, D, OHDSI-COVID-19 consortium

Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case s... by Lane, JCE, Weaves, J, Kostka, K, Alser, O, Alser, O, Prats-Uribe, A, Prats-Uribe, A, Newby, D, Prieto-Alhambra, D

Other Authors: “…OHDSI-COVID-19 consortium…”

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study by Lane, JCE, Weaver, J, Kostka, K, Duarte-Salles, T, Abrahao, MTF, Alghoul, H, Alser, O, Alshammari, TM, Areia, C, Biedermann, P, Banda, JM, Burn, E, Casajust, P, Fišer, K, Hardin, J, Hester, L, Hripcsak, G, Kaas-Hansen, BS, Khosla, S, Kolovos, S, Lynch, KE, Makadia, R, Mehta, PP, Morales, DR, Morgan-Stewart, H, Mosseveld, M, Newby, D, Nyberg, F, Ostropolets, A, Park, RW, Prats-Uribe, A, Rao, GA, Reich, C, Rijnbeek, P, Sena, AG, Shoaibi, A, Spotnitz, M, Subbian, V, Suchard, MA, Vizcaya, D, Wen, H, Wilde, MD, Xie, J, You, SC, Zhang, L, Lovestone, S, Ryan, P, Prieto Alhambra, D

Other Authors: “…OHDSI-COVID-19 consortium…”